Methyllycaconitine (MLA) citrate is a potent, selective, CNS-penetrant, competitive alpha7nAChR antagonist. Methyllycaconitine citrate alleviates amyloid-beta peptides-induced cytotoxicity in SH-SY5Y cells. Methyllycaconitine citrate prevents methamphetamine-induced effects in mouse striatum. Methyllycaconitine citrate can be used for neurological disease research, such as Alzheimers disease [1][2][3].
Molecular Weight:
874.92
Purity:
99.58
CAS Number:
[351344-10-0]
Formula:
C43H58N2O17
Target:
nAChR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted